Description
QIAGEN is the leading provider of sample to insight solutions. Links to websites are provided for convenience and do not imply sponsorship, affiliation or endorsement.
Guidelines when using our Facebook page
We ask that you please adhere to the following guidelines when using our Facebook page:
1. Netiquette
Posting and commenting on our Facebook page should follow these general communications rules:
• Treating all other users as you would like to be treated by them
• Respecting the opinions of others and not trying to force your opinion on anyone else. Everyone has the right to express their own opinion
• Respecting the rights of others
2. Deletion of posts/comments and blocking Facebook accounts
The following actions are examples that are seen as violations of the terms of use. These actions will result in the immediate deletion of posts/comments or, in the case of gross or repeated violations, we will block the user so that he or she is not able to post further content or comments on our page:
• Personal insults or degrading comments of any kind
• Defamatory, anti-constitutional, racist, or pornographic statements or illustrations
• Disparaging comments about institutions, organizations or companies, sexist or racist comments, or hate propaganda
• Any violation of the rights of third parties, in particular copyrights
• Comments that do not relate to the messages under discussion or that are off-topic
• Attacking others or calling for violence of any kind
• Calls to join in demonstrations or rallies of any political orientation
• Offering goods or services, of either a commercial or private nature, or using this Facebook page as an advertising space
• Spam, i.e., any form of automatically generated content or repeatedly posting the same comment
3. Privacy policy
We created this Facebook page in order to connect and facilitate with interested people an exchange about science, biotechnology, healthcare, molecular diagnostics, and other QIAGEN-related topics. The Privacy Policy covers how we handle personal data, which is submitted to Facebook by clicking the “Like” button on our Facebook page. This data is also accessible to QIAGEN. The data we receive from Facebook contains:
• Age demographics
• Place of residence (country and city)
• Gender
• Language
• Activity statistics/rate of all people using our page
Facebook provides this data exclusively in a summarized form. QIAGEN does not receive data on individuals or small user groups. We don’t share the data with third parties. User data is used exclusively to administer our Facebook page and to learn more about which topics are of interest to our followers so that we can further improve our page’s offering.
4. Disclaimer
The messages posted in response to our articles reflect the opinions of individual members only. We are not liable for the content of any messages, or for conclusions that may be drawn from such messages. QIAGEN makes no representations or warranties of any kind about the accuracy or completeness of the content.
Tell your friends
RECENT FACEBOOK POSTS
facebook.comScientists have now sequenced the thylacine's genome and finally have some answers about the last surviving member of the Thylacinidae family - animals that roamed the Earth for tens of millions of years. We are proud that the QIAGEN Sample Preparation could contribute to these exciting findings in evolutionary research!
Over the last two days we were happy to host the winners of the QIA AppsLab video contest in our headquarters in Hilden! 📽️🎬 From hundreds of entries, two bright young scientists were chosen. They got a fully equipped lab and the support of our R&D experts to prepare their samples and process them in our Application Lab. What were the experiment highlights? Look out for our upcoming video release to learn more!
Infectious diseases still pose a significant burden on global health. Together with The Clinton Health Access Initiative, QIAGEN is currently preparing an human papillomavirus testing program in Africa. Efficient HPV diagnostics give a chance to begin treatment early, which gives patients a better shot at being cured, and at the same time lowers the cost per treatment.
Thank you NASDAQ, hello New York Stock Exchange !
If you still like to believe in the existence of an actual Yeti, the latest DNA analysis of 24 samples from Asian bears and purported Yetis might disappoint you.
Peter Kerpedjiev, a software engineer who needed a crash course in genetics, compiled a list of the most studied genes of all time — a sort of ‘top hits’ of the human genome, and several other genomes besides. Can you guess them all? 🔎
Cell-Free Technologies wants to take synthetic biology out of the lab and into our homes. This startup based in Cork, Ireland, takes the molecular machinery that cells use to read DNA and produce proteins out of the cell, making it safe to engineer biology outside the lab.
Dr. Richard K. Wilson, executive director of the Institute for Genomic Medicine at Nationwide Children’s Hospital in Columbus, Ohio, has helped drive genomic discoveries and medicine since the 1980s. He reflects on advances in molecular medicine and how interpreting genomic findings will increasingly inform diagnosis and treatment decisions.
QIAGEN is pleased with the ongoing discussions with Health Innovation Manchester in the UK on a project that would aim to accelerate the future of world-leading innovation, translational science, and molecular diagnostics to benefit patients around the globe. We appreciate the enthusiasm and support of the UK government, and their announcement about the new industrial strategy, but note that discussions are not yet completed. The intention is to make a decision on an agreement in 2018. QIAGEN continues to invest in Manchester, and its other sites around the world, to develop Sample to Insight solutions that enable valuable molecular insights that help make improvements in life possible.
An important day for war victims in former Yugoslavia. Watch the massive efforts that have been made to identify the large number of persons who went missing during this tragic conflict.
Today Prof. Pinkwart, NRW- Minister of Commerce, Innovation and Digitization, met us at our headquarters to discuss how to further drive personalized medicine using innovative digital technologies.
Thank you, Association for Molecular Pathology, Salt Lake City and all attendees of #AMP2017 for a great week! The whole QIAGEN team is already looking forward to 2018! Watch our official wrap-up with all the highlights from last week.
Quiz
